In addition, high TACC3 expression was significantly associated with gender (p = 0.013), invasiveness (p < 0.001), tumor grade (p < 0.001), tumor progression (p = 0.001), and T status (p < 0.001) in bladder cancer patients (Table 1). This evidence concerns the gene TACC3 and urinary bladder cancer.